Your browser doesn't support javascript.
loading
Ro 90-7501 Is a Novel Radiosensitizer for Cervical Cancer Cells that Inhibits ATM Phosphorylation.
Tamari, Keisuke; Sano, Keisuke; Li, Zhihao; Seo, Yuji; Otani, Keisuke; Tatekawa, Shotaro; Toratani, Masayasu; Takaoka, Yuji; Takahashi, Yutaka; Minami, Kazumasa; Isohashi, Fumiaki; Koizumi, Masahiko; Ogawa, Kazuhiko.
Affiliation
  • Tamari K; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan tamari@radonc.med.osaka-u.ac.jp.
  • Sano K; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Li Z; Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Seo Y; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Otani K; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Tatekawa S; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Toratani M; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Takaoka Y; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Takahashi Y; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Minami K; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Isohashi F; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Koizumi M; Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Ogawa K; Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Osaka, Japan.
Anticancer Res ; 39(9): 4805-4810, 2019 Sep.
Article in En | MEDLINE | ID: mdl-31519582
BACKGROUND/AIM: Ro 90-7501 has been reported as an inhibitor of the amyloid ß42 fibril assembly that is associated with Alzheimer's disease. The present study aimed to elucidate the radiosensitizing effects of Ro 90-7501 and focused on ATM signaling after irradiation. MATERIALS AND METHODS: Clonogenic survival, apoptosis, and cell-cycle assays as well as western blotting were performed in HeLa cells treated with irradiation and Ro 90-7501. Tumor growth delay assay was also performed using BALB/c-nu mice. RESULTS: The combination of irradiation with Ro 90-7501 showed significant radiosensitizing effects in clonogenic survival and tumor growth delay assays. Ro 90-7501 significantly increased apoptosis and impaired cell cycle after irradiation. Western blotting showed that Ro 90-7501 suppressed the phosphorylation of ATM and its downstream proteins, such as H2AX, Chk1, and Chk2, after irradiation. CONCLUSION: Ro 90-7501 inhibits DNA damage response by inhibiting ATM and has significant radiosensitizing effects on cervical cancer cells.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation-Sensitizing Agents / Benzimidazoles / Ataxia Telangiectasia Mutated Proteins / Amines Limits: Animals / Female / Humans Language: En Journal: Anticancer Res Year: 2019 Document type: Article Affiliation country: Japón Country of publication: Grecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiation-Sensitizing Agents / Benzimidazoles / Ataxia Telangiectasia Mutated Proteins / Amines Limits: Animals / Female / Humans Language: En Journal: Anticancer Res Year: 2019 Document type: Article Affiliation country: Japón Country of publication: Grecia